AstraZeneca PLC
1601.00
20-September-24 11:24:57
15 minutes delayed
Stocks
-4.00
-0.25%
Today's range
1594.50 - 1617.50
ISIN
N/A
Source
Cboe
-
AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer
21 Oct 2023 11:33:24 By NASDAQ US Markets
-
AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses
21 Oct 2023 11:33:23 By NASDAQ US Markets
-
AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA
16 Oct 2023 07:36:08 By NASDAQ US Markets
-
Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL
15 Oct 2023 23:53:04 By NASDAQ US Markets
-
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
03 Oct 2023 09:12:46 By Forbes - World
-
AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln
03 Oct 2023 03:04:52 By NASDAQ US Markets
-
29 Sep 2023 10:53:27 By MarketWatch
-
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
26 Sep 2023 10:10:15 By NASDAQ Stocks
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:07:47 By Forbes - Markets
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:02:57 By Forbes - World
-
22 Sep 2023 05:43:29 By MarketWatch
-
AstraZeneca Reports Positive Results From Phase III Trial With Datopotamab Deruxtecan
22 Sep 2023 02:59:00 By NASDAQ US Markets
-
AZN : Phase III Trial Of FASENRA In Eosinophilic Granulomatosis With Polyangiitis Meets Main Goal
11 Sep 2023 23:09:20 By NASDAQ US Markets
-
AstraZeneca's Tagrisso Plus Chemotherapy Extended Median PFS In EGFR-mutated Advanced Lung Cancer
11 Sep 2023 04:44:24 By NASDAQ US Markets
-
AstraZeneca: FDA Issues CRL Regarding SBLA Of Ultomiris In NMOSD
06 Sep 2023 03:02:17 By NASDAQ US Markets
-
AstraZeneca's Calquence Approved In China For Chronic Lymphocytic Leukaemia
04 Sep 2023 03:53:41 By NASDAQ US Markets
-
AZN October 6th Options Begin Trading
24 Aug 2023 12:27:14 By NASDAQ Stocks
-
AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use
24 Aug 2023 03:30:40 By NASDAQ US Markets
-
Is This Blue Chip Dividend Stock a Buy for Growth Investors?
08 Aug 2023 05:26:56 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q2 2023 Earnings Call Transcript
28 Jul 2023 15:14:43 By NASDAQ US Markets